Projected uptake of sulfadoxine–pyrimethamine for perennial malaria chemoprevention in children under 2 years of age in nine sub-Saharan African countries: an epidemiologically-based 5-year forecast analysis
Abstract Background Perennial malaria chemoprevention (PMC) with sulfadoxine–pyrimethamine (SP) is recommended for children under 2 years of age living in areas of perennial malaria transmission. Initially delivered through the Expanded Programme of Immunization (EPI), recent pilot studies explored...
Saved in:
| Main Authors: | Céline Audibert, Pierre Hugo, Roly Gosling, Charlotte Eddis, Meredith Center, André Marie Tchouatieu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Malaria Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12936-025-05355-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A roadmap for understanding sulfadoxine-pyrimethamine in malaria chemoprevention
by: Thiery Masserey, et al.
Published: (2025-02-01) -
Audit of failure rate of sulfadoxine/pyrimetham combined with chloroquine to treat falciparum malaria at single fourteen-day follow-up
by: C.H. Vaughan Williams, et al.
Published: (2002-03-01) -
Individual and community-level correlates of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: a multilevel analysis of the 2022 national survey
by: Elihuruma Eliufoo Stephano, et al.
Published: (2025-07-01) -
Profile of molecular markers of Sulfadoxine-Pyrimethamine-resistant Plasmodium falciparum in individuals living in southern area of Brazzaville, Republic of Congo
by: Jean Claude Djontu, et al.
Published: (2024-12-01) -
Investigating the dynamics of Plasmodium falciparum gametocyte carriage in expectant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Kilifi, study protocol [version 2; peer review: 3 approved]
by: Isabella Oyier, et al.
Published: (2025-04-01)